Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis. N Engl J Med. 2024 Sep 26; 391(12):1119-1129.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Colitis, Ulcerative
Double-Blind Method
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Remission Induction
Treatment Outcome
Tumor Necrosis Factor Ligand Superfamily Member 15
authors with profiles
David T. Rubin